» Articles » PMID: 38791985

Hyaluronic Acid Interacting Molecules Mediated Crosstalk Between Cancer Cells and Microenvironment from Primary Tumour to Distant Metastasis

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2024 May 25
PMID 38791985
Authors
Affiliations
Soon will be listed here.
Abstract

Hyaluronic acid (HA) is a prominent component of the extracellular matrix, and its interactions with HA-interacting molecules (HAIMs) play a critical role in cancer development and disease progression. This review explores the multifaceted role of HAIMs in the context of cancer, focusing on their influence on disease progression by dissecting relevant cellular and molecular mechanisms in tumour cells and the tumour microenvironment. Cancer progression can be profoundly affected by the interactions between HA and HAIMs. They modulate critical processes such as cell adhesion, migration, invasion, and proliferation. The TME serves as a dynamic platform in which HAIMs contribute to the formation of a unique niche. The resulting changes in HA composition profoundly influence the biophysical properties of the TME. These modifications in the TME, in conjunction with HAIMs, impact angiogenesis, immune cell recruitment, and immune evasion. Therefore, understanding the intricate interplay between HAIMs and HA within the cancer context is essential for developing novel therapeutic strategies. Targeting these interactions offers promising avenues for cancer treatment, as they hold the potential to disrupt critical aspects of disease progression and the TME. Further research in this field is imperative for advancing our knowledge and the treatment of cancer.

Citing Articles

Correction: Xu et al. Hyaluronic Acid Interacting Molecules Mediated Crosstalk between Cancer Cells and Microenvironment from Primary Tumour to Distant Metastasis. 2024, , 1907.

Xu Y, Benedikt J, Ye L Cancers (Basel). 2025; 17(3).

PMID: 39941926 PMC: 11817104. DOI: 10.3390/cancers17030549.


Extracellular Matrix as a Target in Melanoma Therapy: From Hypothesis to Clinical Trials.

Mayasin Y, Osinnikova M, Kharisova C, Kitaeva K, Filin I, Gorodilova A Cells. 2024; 13(22).

PMID: 39594665 PMC: 11592585. DOI: 10.3390/cells13221917.

References
1.
Pibuel M, Poodts D, Molinari Y, Diaz M, Amoia S, Byrne A . The importance of RHAMM in the normal brain and gliomas: physiological and pathological roles. Br J Cancer. 2022; 128(1):12-20. PMC: 9814267. DOI: 10.1038/s41416-022-01999-w. View

2.
Yang B, Yang B, Savani R, Turley E . Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein. EMBO J. 1994; 13(2):286-96. PMC: 394807. DOI: 10.1002/j.1460-2075.1994.tb06261.x. View

3.
Coles C, Shen Y, Tenney A, Siebold C, Sutton G, Lu W . Proteoglycan-specific molecular switch for RPTPσ clustering and neuronal extension. Science. 2011; 332(6028):484-8. PMC: 3154093. DOI: 10.1126/science.1200840. View

4.
McLaughlin M, Patin E, Pedersen M, Wilkins A, Dillon M, Melcher A . Inflammatory microenvironment remodelling by tumour cells after radiotherapy. Nat Rev Cancer. 2020; 20(4):203-217. DOI: 10.1038/s41568-020-0246-1. View

5.
Jiang X, Bai X, Li B, Li Y, Xia K, Wang M . Plasma Inter-Alpha-Trypsin Inhibitor Heavy Chains H3 and H4 Serve as Novel Diagnostic Biomarkers in Human Colorectal Cancer. Dis Markers. 2019; 2019:5069614. PMC: 6701429. DOI: 10.1155/2019/5069614. View